Elicio Therapeutics (ELTX) Treasury Shares (2020 - 2026)
Elicio Therapeutics (ELTX) reported Treasury Shares of $150000.0 for Q1 2026, little changed on a YoY basis from $150000.0 in Q1 2025, and little changed quarter-over-quarter from $150000.0 in Q4 2025.
Elicio Therapeutics (ELTX) Treasury Shares (2020 - 2026) Analysis & Trends
Elicio Therapeutics has reported Treasury Shares for 6 years, with the latest figure at $150000.0 in Q1 2026.
- For the quarter ending Q1 2026, Treasury Shares changed 0.0% year-over-year to $150000.0; the trailing twelve-month figure through Mar 2026 stood at $150000.0 (changed 0.0% YoY), and the FY2025 full-year result was $150000.0, changed 0.0% from the prior year.
- Treasury Shares for Q1 2026 stood at $150000.0, roughly flat from $150000.0 in the prior quarter.
- The five-year high for Treasury Shares was $14455.0 in Q2 2023, with the low at $14455.0 in Q2 2023.
- Historically, Treasury Shares has averaged $14455.0 across 4 years, with a median of $14455.0 in 2023.
- The largest YoY upside for Treasury Shares was 0.0% in 2024 against a maximum downside of 0.0% in 2024.
- Elicio Therapeutics' Treasury Shares stood at $150000.0 in 2023, then changed by 0.0% to $150000.0 in 2024, then changed by 0.0% to $150000.0 in 2025, then changed by 0.0% to $150000.0 in 2026.
- The last three Treasury Shares figures came in at $150000.0 (Q1 2026), $150000.0 (Q4 2025), and $150000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Elicio Therapeutics | 70.12 Mn | 55.17 Mn | - | 150,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 150,000.00 |
| Mar 31, 2026 | 14,455.00 |
| Mar 31, 2026 | 150,000.00 |
| Mar 31, 2026 | 14,455.00 |
| Dec 31, 2025 | 14,455.00 |
| Dec 31, 2025 | 150,000.00 |
| Dec 31, 2025 | 150,000.00 |
| Dec 31, 2025 | 14,455.00 |
| Sep 30, 2025 | 150,000.00 |
| Sep 30, 2025 | 14,455.00 |
| Sep 30, 2025 | 14,455.00 |
| Sep 30, 2025 | 150,000.00 |
| Jun 30, 2025 | 150,000.00 |
| Jun 30, 2025 | 150,000.00 |
| Jun 30, 2025 | 14,455.00 |
| Jun 30, 2025 | 14,455.00 |
| Mar 31, 2025 | 14,455.00 |
| Mar 31, 2025 | 14,455.00 |
| Mar 31, 2025 | 150,000.00 |
| Mar 31, 2025 | 150,000.00 |